IOL CHEMICALS & PHARM. | MOREPEN LABS | IOL CHEMICALS & PHARM./ MOREPEN LABS |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.6 | 34.0 | 39.9% | View Chart |
P/BV | x | 1.5 | 3.4 | 44.9% | View Chart |
Dividend Yield | % | 1.0 | 0.0 | - |
IOL CHEMICALS & PHARM. MOREPEN LABS |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
MOREPEN LABS Mar-23 |
IOL CHEMICALS & PHARM./ MOREPEN LABS |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 55 | 979.4% | |
Low | Rs | 272 | 24 | 1,151.0% | |
Sales per share (Unadj.) | Rs | 377.6 | 27.7 | 1,361.8% | |
Earnings per share (Unadj.) | Rs | 23.7 | 0.8 | 3,132.3% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 1.3 | 2,422.2% | |
Dividends per share (Unadj.) | Rs | 4.00 | 0 | - | |
Avg Dividend yield | % | 1.0 | 0 | - | |
Book value per share (Unadj.) | Rs | 256.8 | 14.7 | 1,743.5% | |
Shares outstanding (eoy) | m | 58.71 | 511.17 | 11.5% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 1.4 | 75.7% | |
Avg P/E ratio | x | 17.1 | 51.8 | 32.9% | |
P/CF ratio (eoy) | x | 12.8 | 30.1 | 42.6% | |
Price / Book Value ratio | x | 1.6 | 2.7 | 59.1% | |
Dividend payout | % | 16.9 | 0 | - | |
Avg Mkt Cap | Rs m | 23,743 | 20,051 | 118.4% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 1,547 | 108.7% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 14,175 | 156.4% | |
Other income | Rs m | 256 | 61 | 417.6% | |
Total revenues | Rs m | 22,427 | 14,237 | 157.5% | |
Gross profit | Rs m | 2,257 | 795 | 283.7% | |
Depreciation | Rs m | 462 | 279 | 165.3% | |
Interest | Rs m | 165 | 20 | 831.4% | |
Profit before tax | Rs m | 1,887 | 558 | 338.4% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 171 | 289.9% | |
Profit after tax | Rs m | 1,391 | 387 | 359.8% | |
Gross profit margin | % | 10.2 | 5.6 | 181.4% | |
Effective tax rate | % | 26.2 | 30.6 | 85.7% | |
Net profit margin | % | 6.3 | 2.7 | 230.0% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 7,562 | 127.8% | |
Current liabilities | Rs m | 5,025 | 3,212 | 156.5% | |
Net working cap to sales | % | 20.9 | 30.7 | 68.2% | |
Current ratio | x | 1.9 | 2.4 | 81.7% | |
Inventory Days | Days | 43 | 18 | 238.9% | |
Debtors Days | Days | 8 | 678 | 1.2% | |
Net fixed assets | Rs m | 11,017 | 3,543 | 310.9% | |
Share capital | Rs m | 587 | 1,022 | 57.4% | |
"Free" reserves | Rs m | 14,490 | 6,507 | 222.7% | |
Net worth | Rs m | 15,077 | 7,529 | 200.3% | |
Long term debt | Rs m | 0 | 9 | 0.0% | |
Total assets | Rs m | 20,684 | 11,105 | 186.3% | |
Interest coverage | x | 12.5 | 29.1 | 42.7% | |
Debt to equity ratio | x | 0 | 0 | 0.0% | |
Sales to assets ratio | x | 1.1 | 1.3 | 84.0% | |
Return on assets | % | 7.5 | 3.7 | 205.5% | |
Return on equity | % | 9.2 | 5.1 | 179.7% | |
Return on capital | % | 13.6 | 7.7 | 177.6% | |
Exports to sales | % | 26.7 | 39.9 | 67.0% | |
Imports to sales | % | 0 | 30.5 | 0.0% | |
Exports (fob) | Rs m | 5,930 | 5,657 | 104.8% | |
Imports (cif) | Rs m | NA | 4,324 | 0.0% | |
Fx inflow | Rs m | 5,930 | 5,657 | 104.8% | |
Fx outflow | Rs m | 6,052 | 4,444 | 136.2% | |
Net fx | Rs m | -122 | 1,213 | -10.0% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | -912 | -134.1% | |
From Investments | Rs m | -1,200 | -465 | 258.0% | |
From Financial Activity | Rs m | -41 | 1,435 | -2.9% | |
Net Cashflow | Rs m | -18 | 59 | -31.4% |
Indian Promoters | % | 48.2 | 38.2 | 126.1% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 4.0 | 42.4% | |
FIIs | % | 1.4 | 1.9 | 75.7% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 61.8 | 83.9% | |
Shareholders | 130,003 | 336,019 | 38.7% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB MANKIND PHARMA
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | MOREPEN LABS | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.80% | -0.77% | 0.34% |
1-Month | 4.69% | 11.26% | 0.25% |
1-Year | -3.18% | 77.70% | 54.31% |
3-Year CAGR | -13.27% | -5.68% | 15.04% |
5-Year CAGR | 17.19% | 24.89% | 19.87% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the MOREPEN LABS share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of MOREPEN LABS the stake stands at 38.2%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of MOREPEN LABS.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
MOREPEN LABS paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of MOREPEN LABS.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on positive note, Indian share markets continued the momentum as the session progressed and ended on firm footing.